Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries

Anna-Elina Lehtinen; Fariba Baghaei; Jan Astermark; Pål Andre Holme

doi:10.1111/hae.14585

Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries

Anna-Elina Lehtinen, Fariba Baghaei, Jan Astermark, Pål Andre Holme

HUS Comprehensive Cancer Center

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Haemophilia
Volume	28
Issue number	5
Pages (from-to)	713-719
Number of pages	7
ISSN	1351-8216
DOIs	https://doi.org/10.1111/hae.14585
Publication status	Published - Sept 2022
MoE publication type	A1 Journal article-refereed

Fields of Science

factor IX Fc fusion protein
factor VIII-Fc fusion protein
haemophilia A
haemophilia B
recombinant fusion proteins
surgical procedures
PERIOPERATIVE MANAGEMENT
PHASE-3
CONCENTRATE
CHILDREN
3126 Surgery, anesthesiology, intensive care, radiology

Access to Document

10.1111/hae.14585

Cite this

@article{ac66ce90b5e14b86b35b4a405ea27f32,

title = "Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries",

keywords = "factor IX Fc fusion protein, factor VIII-Fc fusion protein, haemophilia A, haemophilia B, recombinant fusion proteins, surgical procedures, PERIOPERATIVE MANAGEMENT, PHASE-3, CONCENTRATE, CHILDREN, 3126 Surgery, anesthesiology, intensive care, radiology",

author = "Anna-Elina Lehtinen and Fariba Baghaei and Jan Astermark and Holme, {P{\aa}l Andre}",

year = "2022",

month = sep,

doi = "10.1111/hae.14585",

language = "English",

volume = "28",

pages = "713--719",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "John Wiley and Sons Inc",

number = "5",

}

Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries. / Lehtinen, Anna-Elina; Baghaei, Fariba; Astermark, Jan et al.
In: Haemophilia, Vol. 28, No. 5, 09.2022, p. 713-719.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins

T2 - Real-world experience in the Nordic countries

AU - Lehtinen, Anna-Elina

AU - Baghaei, Fariba

AU - Astermark, Jan

AU - Holme, Pål Andre

PY - 2022/9

Y1 - 2022/9

KW - factor IX Fc fusion protein

KW - factor VIII-Fc fusion protein

KW - haemophilia A

KW - haemophilia B

KW - recombinant fusion proteins

KW - surgical procedures

KW - PERIOPERATIVE MANAGEMENT

KW - PHASE-3

KW - CONCENTRATE

KW - CHILDREN

KW - 3126 Surgery, anesthesiology, intensive care, radiology

U2 - 10.1111/hae.14585

DO - 10.1111/hae.14585

M3 - Article

SN - 1351-8216

VL - 28

SP - 713

EP - 719

JO - Haemophilia

JF - Haemophilia

IS - 5

ER -